Corrigendum
Corrigendum to “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China”
Table 5
Information of the deceased patients with SJS/TEN in this study (
).
| Phenotype | Sex | Age, y | Underlying disease | SCORTEN | Culprit drugs | Treatment |
| SJS | M | 51 | Chronic renal failure, diabetes | 4 | Allopurinol | Systemic steroids | TEN | M | 70 | Nil | 6 | Antibiotics | Systemic steroids | TEN | F | 58 | Aneurysm, subarachnoid hemorrhage | NA | Antibiotics | Systemic steroids | TEN | F | 67 | Rheumatic heart disease, mitral insufficiency | NA | Antibiotics and compound with aminopyrine, phenacetin, caffeine, phenobarbital | Systemic steroids with IVIG use in the late stage | TEN | F | 71 | Coronary heart disease, hypertension, diabetes, diabetic nephropathy | 4 | Calcium dobesilate | Systemic steroids with IVIG use in the early stage | TEN | M | 62 | Hypertension, diabetes | NA | Antibiotics | Systemic steroids with IVIG use in the early stage | TEN | M | 94 | Coronary heart disease, cardiac insufficiency, hypertension, diabetes, interstitial lung disease | NA | Antibiotics | Systemic steroids with IVIG use in the early stage | TEN | M | 62 | Hypertension, diabetes, chronic renal failure, hyperuricemia | NA | Allopurinol | Systemic steroids | TEN | M | 3 | Nil | 2 | Antibiotics | Systemic steroids |
|
|
IVIG use in the early stage ≤ 7 days of onset, IVIG use in the late stage ≥ 7 days of onset. NA: not available.
|